As a critical effector downstream of BCL10 activation, NF-κB signaling simultaneously promotes tumor cell survival and proliferation while suppressing antitumor immunity through immune cell dysregulation, thereby enabling tumor immune evasion (43). Here, NFKB1 is linked to neoplasm.